APA

van der Gaast A., Vlastuin M., Kok T. C. & Splinter T. A. (19930222). What is the optimal dose and duration of treatment with etoposide? II. Comparative pharmacokinetic study of three schedules: 1 x 100 mg, 2 x 50 mg, and 4 x 25 mg of oral etoposide daily for 21 days. : Seminars in oncology.

Chicago

van der Gaast A, Vlastuin M, Kok T C and Splinter T A. 19930222. What is the optimal dose and duration of treatment with etoposide? II. Comparative pharmacokinetic study of three schedules: 1 x 100 mg, 2 x 50 mg, and 4 x 25 mg of oral etoposide daily for 21 days. : Seminars in oncology.

Harvard

van der Gaast A., Vlastuin M., Kok T. C. and Splinter T. A. (19930222). What is the optimal dose and duration of treatment with etoposide? II. Comparative pharmacokinetic study of three schedules: 1 x 100 mg, 2 x 50 mg, and 4 x 25 mg of oral etoposide daily for 21 days. : Seminars in oncology.

MLA

van der Gaast A, Vlastuin M, Kok T C and Splinter T A. What is the optimal dose and duration of treatment with etoposide? II. Comparative pharmacokinetic study of three schedules: 1 x 100 mg, 2 x 50 mg, and 4 x 25 mg of oral etoposide daily for 21 days. : Seminars in oncology. 19930222.